Evaluation of Opioid Prescriptions After Urogynecologic Surgery Within a Large Health Care Organization: How Much Are We Prescribing?

Female Pelvic Medicine & Reconstructive Surgery
Kristen BuonoEmily Whitcomb

Abstract

Data regarding postoperative opioid prescriptions for patients undergoing urogynecologic surgery are sparse. Our objective was to quantify surgeon prescribing patterns for patients undergoing surgery for pelvic organ prolapse or stress urinary incontinence. Patients who underwent surgery for pelvic organ prolapse or SUI within a large health care maintenance organization were identified by procedural codes within the electronic medical record. Medical records were reviewed for demographic and clinical data. Our primary objective was to describe initial postoperative morphine milligram equivalent (MME) dosages for patients undergoing various urogynecologic surgeries. Secondary objectives were to evaluate rates of postoperative non-opioid analgesic prescriptions, presence of additional postoperative opioid prescriptions within 90 days of surgery, and to characterize prescribing patterns of surgeons from different specialties. We evaluated 855 patients undergoing 7 urogynecologic surgeries. There was wide variation in the quantity of MME prescribed to patients undergoing different urogynecologic surgeries, and the mean MME ranged from 137.6 mg after a colpocleisis to 214.1 mg after a laparoscopic uterosacral ligament suspension. L...Continue Reading

References

Apr 22, 2015·American Journal of Preventive Medicine·Benjamin LevyChristopher M Jones
Oct 20, 2015·The American Journal of Emergency Medicine·Roneet LevChristopher J Coyne
Jan 14, 2016·The New England Journal of Medicine·Wilson M ComptonGrant T Baldwin
Mar 16, 2016·JAMA : the Journal of the American Medical Association·Hannah WunschMark D Neuman
Mar 22, 2016·American Journal of Obstetrics and Gynecology·Brian T BatemanNiteesh K Choudhry
Jun 14, 2016·JAMA Internal Medicine·Alene Kennedy-HendricksColleen L Barry
Jul 13, 2016·Female Pelvic Medicine & Reconstructive Surgery·Carolyn W SwensonMitchell B Berger
Mar 3, 2018·Journal of the American College of Surgeons·Mayo H FujiiCharles D MacLean

❮ Previous
Next ❯

Citations

Jan 6, 2021·Southern Medical Journal·Alexis A DieterErin T Carey
Jul 13, 2020·American Journal of Obstetrics and Gynecology·Marcella G Willis-GrayJennifer M Wu
May 10, 2020·Female Pelvic Medicine & Reconstructive Surgery·Sarah Keenan Larkin EvansMegan E Tarr
Aug 19, 2021·International Urogynecology Journal·Magdalena Emilia GrzybowskaDariusz Grzegorz Wydra
Oct 21, 2021·Female Pelvic Medicine & Reconstructive Surgery·Krista M L ReaganJaime B Long

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.